{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":15,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":15,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"5858a2241443","filters":{"venue":"Clinical Medicine Insights Therapeutics"}},"results":[{"id":"W1989502045","doi":"10.4137/cmt.s3783","title":"Lapatinib, a Dual-Targeted Small Molecule Inhibitor of EGFR and HER2, in HER2-Amplified Breast Cancer: From Bench to Bedside","year":2011,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Terry Fox Foundation","keywords":"Lapatinib; Trastuzumab; Breast cancer; Cancer research; Medicine; Tyrosine kinase; Tyrosine-kinase inhibitor; Epidermal growth factor receptor; Metastatic breast cancer; Cancer; Targeted therapy; Pertuzumab; Letrozole; Oncology; Internal medicine; Receptor; Tamoxifen","authors":[{"name":"Roger Y. Tsang","is_ca":false},{"name":"Saeed Sadeghi","is_ca":false},{"name":"Richard S. Finn","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1881386438902378,"gpt":0.4205964844946525,"spread":0.2324578406044146,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009217748,0.0004055147,0.001405459,0.0003318842,0.00005595083,0.00001046471,0.000308653,0.0004568688,0.0008153943],"category_scores_gemma":[0.0005369924,0.0002965606,0.0001325081,0.0007770206,0.0008615247,0.00005665349,0.0001965381,0.001057989,0.0000269038],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001380629,"about_ca_system_score_gemma":0.000499358,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007467125,"about_ca_topic_score_gemma":0.002485818,"domain_scores_codex":[0.9956126,0.0004155079,0.001802917,0.0008333804,0.0007410267,0.0005946356],"domain_scores_gemma":[0.9966149,0.0009663487,0.0002994488,0.0008687962,0.0004891451,0.0007613144],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007960469,0.0039113,0.7006438,0.000657806,0.001197645,0.0008598748,0.0279428,0.000003551856,0.0699002,0.0006806348,0.00316946,0.1830724],"study_design_scores_gemma":[0.01358773,0.006799127,0.9315073,0.003585053,0.0005789172,0.00006002181,0.00183486,0.0003526096,0.02355733,0.002594531,0.01480275,0.0007396999],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.984028,0.003476724,0.00008578692,0.008040126,0.0007047638,0.001168256,0.00006831301,0.00006630378,0.002361701],"genre_scores_gemma":[0.9858797,0.002799896,0.00159343,0.008247524,0.001068418,0.0001039274,0.00003263604,0.0000894745,0.0001850102],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2308635,"threshold_uncertainty_score":0.9999487,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2069864063","doi":"10.4137/cmt.s11675","title":"Safety and Efficacy of Delamanid in the Treatment of Multidrug-Resistant Tuberculosis (MDR-TB)","year":2013,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Bedaquiline; Tuberculosis; Multiple drug resistance; Isoniazid; Antibiotics; Drug resistance; Internal medicine; Intensive care medicine; Clinical trial; Incidence (geometry); Mycobacterium tuberculosis; Microbiology; Pathology; Biology","authors":[{"name":"Stephen K. Field","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1024885167783378,"gpt":0.4154060033906332,"spread":0.3129174866122953,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009979544,0.0002401077,0.001271994,0.0001698817,0.00004828187,0.000003537111,0.0001900381,0.0002443065,0.0001016263],"category_scores_gemma":[0.0009715862,0.0001115403,0.0002010361,0.0003174223,0.001300773,0.00004300939,0.00003062861,0.0003485561,0.00001290226],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005090262,"about_ca_system_score_gemma":0.00007300278,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000890806,"about_ca_topic_score_gemma":0.0001364011,"domain_scores_codex":[0.9964517,0.0007917078,0.001680962,0.0003519368,0.0003786068,0.0003451022],"domain_scores_gemma":[0.9913066,0.007333371,0.0002558448,0.0006707286,0.0002124163,0.0002210458],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.008458662,0.01296814,0.406335,0.0004784179,0.00276358,0.0001307035,0.01651101,0.00001417651,0.02673994,0.004393602,0.001782721,0.5194241],"study_design_scores_gemma":[0.01159653,0.01285753,0.9386151,0.0003050664,0.0005019348,0.00002364399,0.001070319,0.001653956,0.0007545259,0.0009151757,0.03156049,0.00014567],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9693295,0.006557122,0.00003012202,0.02120051,0.0001232794,0.001147638,0.000004224401,0.00001386954,0.00159379],"genre_scores_gemma":[0.9601102,0.03618713,0.0002698317,0.003023739,0.00027496,0.00003139145,0.00001830474,0.00001939056,0.00006503331],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5322802,"threshold_uncertainty_score":0.4792752,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2759644066","doi":"10.1177/1179559x17731801","title":"Brexpiprazole in the Treatment of Major Depressive Disorder","year":2017,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Treatment of Major Depression","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network; St. Michael's Hospital","funders":"Ontario Brain Institute; Massachusetts General Hospital","keywords":"Partial agonist; Aripiprazole; PsycINFO; Major depressive disorder; Adjunctive treatment; Antipsychotic; Antidepressant; Medicine; Meta-analysis; Psychology; Atypical antipsychotic; Psychiatry; Psychotherapist; MEDLINE; Schizophrenia (object-oriented programming); Agonist; Internal medicine; Anxiety; Mood; Receptor","authors":[{"name":"Maryam I. Al Shirawi","is_ca":true},{"name":"Nicole E. Edgar","is_ca":true},{"name":"Sidney H. Kennedy","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1311998809784387,"gpt":0.4398751764897023,"spread":0.3086752955112636,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003014575,0.0002686819,0.0008179337,0.0000962936,0.0002125159,0.00001653345,0.00044686,0.0002207941,0.00007885721],"category_scores_gemma":[0.0002840228,0.00012109,0.0002090827,0.00008991348,0.0009867674,0.00008549713,0.00004137112,0.0002666222,0.00002253185],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004369243,"about_ca_system_score_gemma":0.00007302463,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000168919,"about_ca_topic_score_gemma":0.0001246285,"domain_scores_codex":[0.9977999,0.0002154065,0.0008834885,0.0003750914,0.0004763868,0.0002497214],"domain_scores_gemma":[0.9963407,0.001168845,0.0005044221,0.001755581,0.0001080724,0.0001224038],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001089279,0.007002507,0.6805428,0.00005538363,0.0005143716,0.000370327,0.004517832,0.000001528936,0.001152719,0.0007288582,0.0004044077,0.30362],"study_design_scores_gemma":[0.02267743,0.007014874,0.8675395,0.0004445448,0.0009234024,0.00003587588,0.0005339351,0.0001370656,0.00158961,0.001931914,0.09701106,0.0001607453],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9664819,0.007701647,0.00006108542,0.0172428,0.0005925301,0.0009590642,0.000003288999,0.0000291595,0.006928489],"genre_scores_gemma":[0.9901857,0.006960316,0.0001613838,0.00141969,0.0006722505,0.00005485824,0.00001584677,0.00002882919,0.0005010798],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3034592,"threshold_uncertainty_score":0.4937907,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2761151032","doi":"10.1177/1179559x17734227","title":"Efficacy of Continuous Positive Airway Pressure Treatment in Patients with Cardiac Arrhythmia and Obstructive Sleep Apnea: What is the Evidence?","year":2017,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Obstructive Sleep Apnea Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Toronto Rehabilitation Institute; Sunnybrook Health Science Centre; Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Continuous positive airway pressure; Obstructive sleep apnea; Cardiology; Cardiac arrhythmia; Internal medicine; Observational study; Heart failure; Positive airway pressure; Ejection fraction; Confounding; Coronary artery disease; Sleep apnea; Intensive care medicine; Atrial fibrillation","authors":[{"name":"Asmaa M. Abumuamar","is_ca":true},{"name":"Tatyana Mollayeva","is_ca":true},{"name":"Paul Sandor","is_ca":true},{"name":"David Newman","is_ca":true},{"name":"Kumaraswamy Nanthakumar","is_ca":true},{"name":"Colin M. Shapiro","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05185066215065454,"gpt":0.3690471978300446,"spread":0.3171965356793901,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0005413404,0.0003800241,0.001300726,0.0001220126,0.0002604882,0.00006380885,0.0003366935,0.000255092,0.00003115834],"category_scores_gemma":[0.0008116114,0.0001833136,0.0001686704,0.0001651226,0.003437287,0.0003888578,0.0001509375,0.0006540547,0.000005399945],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000952796,"about_ca_system_score_gemma":0.00008509839,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001171915,"about_ca_topic_score_gemma":0.00001702809,"domain_scores_codex":[0.9968137,0.0004695998,0.0008446164,0.0006669238,0.0008150127,0.0003901141],"domain_scores_gemma":[0.9937209,0.003302799,0.0005740426,0.001419948,0.0007282051,0.0002541455],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004942545,0.0004631802,0.5546551,0.00005496611,0.001858805,0.0000437719,0.005968557,0.0000011274,0.0000965692,0.0001415612,0.000007403596,0.4317665],"study_design_scores_gemma":[0.01281859,0.008099739,0.9720799,0.001057775,0.001418765,0.000006070577,0.00129858,0.0002006661,0.001105888,0.0001906549,0.001530274,0.0001930976],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9785169,0.009056369,0.00002880247,0.008766029,0.0006175966,0.002569782,0.00001471382,0.00001636466,0.0004133857],"genre_scores_gemma":[0.9960609,0.00247666,0.000123052,0.0005178267,0.0006072501,0.00004324672,0.000009836951,0.000043038,0.0001181531],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4315733,"threshold_uncertainty_score":0.9992748,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1965329525","doi":"10.4137/cmt.s4012","title":"Varenicline: Smoking Cessation in Patients with Medical and Psychiatric Comorbidity","year":2010,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Provincial Laboratory of Public Health; University of Alberta","funders":"","keywords":"Varenicline; Smoking cessation; Medicine; Comorbidity; Psychiatry; Mental illness; Addiction; Nicotine replacement therapy; Pharmacotherapy; Nicotine; Tolerability; Mental health; Internal medicine; Adverse effect","authors":[{"name":"Serena Tonstad","is_ca":false},{"name":"Charl Els","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05322821542743384,"gpt":0.3753441157299476,"spread":0.3221159003025138,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008944968,0.000208953,0.0005064153,0.0002074828,0.00008378064,0.00001236699,0.0001300016,0.0004749813,0.0002394342],"category_scores_gemma":[0.0005825753,0.0001293559,0.00004729116,0.0004239187,0.0005344779,0.00009420368,0.00003346506,0.001457229,0.000001818012],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002646244,"about_ca_system_score_gemma":0.0001437754,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004035876,"about_ca_topic_score_gemma":0.0001142733,"domain_scores_codex":[0.9974945,0.0001221821,0.0008401255,0.0004005274,0.0009209694,0.0002216553],"domain_scores_gemma":[0.9981997,0.0006644823,0.0002164061,0.0003981233,0.0002276243,0.0002936671],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002733763,0.0006083206,0.9488732,0.00002203201,0.00003831632,0.00001629747,0.0001948441,1.185792e-7,0.00001418017,0.0002363148,0.0000580222,0.04966503],"study_design_scores_gemma":[0.01060351,0.0012954,0.9841169,0.0002197283,0.00031371,0.00001627506,0.0000527275,0.0001437055,0.00002441376,0.000527324,0.002529955,0.0001563794],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938854,0.00008817141,0.0001611016,0.003399573,0.001422125,0.0003664802,0.000001257985,0.00006273084,0.0006131749],"genre_scores_gemma":[0.9956408,0.0003015333,0.0001601045,0.002953836,0.0008105161,0.000009911878,0.00007276643,0.00002955806,0.00002096588],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04950865,"threshold_uncertainty_score":0.6331018,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1981981010","doi":"10.4137/cmt.s5884","title":"Efficacy and Safety of Galantamine Hydrobromide in the Treatment of Mild to Moderate Dementia","year":2010,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Galantamine; Dementia; Mood; Placebo; Medicine; Nausea; Psychiatry; Disease; Internal medicine; Donepezil; Alternative medicine","authors":[{"name":"Mark Oremus","is_ca":true},{"name":"Pasqualina Santaguida","is_ca":true},{"name":"Parminder Raina","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08946186334557535,"gpt":0.4202218599304458,"spread":0.3307599965848704,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007907799,0.0001771878,0.000653769,0.000158578,0.00004129625,0.000004697978,0.0001437358,0.00011373,0.00009456436],"category_scores_gemma":[0.0001724698,0.0000900634,0.00008433645,0.0002831769,0.0005840947,0.00002639607,0.00002952006,0.0002973162,0.000004538565],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001179894,"about_ca_system_score_gemma":0.0000715995,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004624311,"about_ca_topic_score_gemma":0.00008734601,"domain_scores_codex":[0.9979269,0.0002120097,0.0009365943,0.0002758378,0.0004188824,0.000229793],"domain_scores_gemma":[0.9977483,0.001365738,0.0001381735,0.0004181614,0.0001639608,0.0001656808],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01220569,0.01449502,0.663726,0.0002279498,0.001602449,0.000114944,0.009664385,0.000003575628,0.08996363,0.001544756,0.0002208476,0.2062307],"study_design_scores_gemma":[0.01724737,0.01778721,0.9299123,0.0002734079,0.0007770715,0.00001804448,0.0003601011,0.0003658222,0.01284794,0.0005348473,0.01975024,0.0001256154],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912556,0.0008875127,0.0001209093,0.00456157,0.0001649642,0.001131908,0.000003260119,0.00000867917,0.001865584],"genre_scores_gemma":[0.994188,0.003725763,0.0002412919,0.001469394,0.0002127864,0.00002291924,0.0000135334,0.00001417397,0.0001121043],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2661863,"threshold_uncertainty_score":0.3672679,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2029911300","doi":"10.4137/cmt.s2213","title":"Emerging Therapies for the Management of Multiple Sclerosis","year":2010,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; Apotex (Canada); Health Sciences Centre","funders":"","keywords":"Medicine; Multiple sclerosis; Data extraction; Clinical trial; MEDLINE; Cochrane Library; Randomized controlled trial; Placebo; Transplantation; Intensive care medicine; Internal medicine; Alternative medicine; Pathology; Immunology","authors":[{"name":"Michael Namaka","is_ca":true},{"name":"Christine Leong","is_ca":true},{"name":"Michael Prout","is_ca":true},{"name":"Josée-Anne Le Dorze","is_ca":true},{"name":"Mike Limerick","is_ca":true},{"name":"Emma E. Frost","is_ca":true},{"name":"Farid Esfahani","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2704279329610191,"gpt":0.4403211410679815,"spread":0.1698932081069624,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001377569,0.0002556708,0.0007249187,0.0001070722,0.0002756421,0.00001093394,0.000415054,0.0001646121,0.0001164593],"category_scores_gemma":[0.0005792296,0.0001265785,0.0003116758,0.0003214369,0.001673027,0.00004760052,0.0001403943,0.0006812185,0.000008994468],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001610694,"about_ca_system_score_gemma":0.00004478529,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000205355,"about_ca_topic_score_gemma":0.00003869371,"domain_scores_codex":[0.9974266,0.00008946418,0.001053142,0.0003931907,0.0006516992,0.0003858721],"domain_scores_gemma":[0.993283,0.004833765,0.0002649401,0.0009474524,0.0004996386,0.0001711634],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001259162,0.0008934192,0.02829082,0.0005685274,0.004896452,0.000006752966,0.002996993,0.000003088491,0.05844285,0.004111636,0.002198945,0.8963314],"study_design_scores_gemma":[0.01317539,0.00199788,0.5424583,0.000945046,0.001598303,0.000005095369,0.004292895,0.004499706,0.00514912,0.001406148,0.4241619,0.0003101809],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9183064,0.01143089,0.006347422,0.05101983,0.004068647,0.004827142,0.00001813923,0.0001917449,0.003789787],"genre_scores_gemma":[0.9701657,0.02064045,0.005426512,0.001973901,0.001177054,0.0001817818,0.000008276774,0.00004801932,0.0003782963],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8960212,"threshold_uncertainty_score":0.6164337,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2013609844","doi":"10.4137/cmt.s4500","title":"Gastric Acid-Related Diseases: Focus on Esomeprazole","year":2010,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Esomeprazole; Omeprazole; Medicine; Rabeprazole; Gastroenterology; Proton-pump inhibitor; Clopidogrel; Internal medicine; Gastric acid; Famotidine; Helicobacter pylori; Aspirin; Stomach","authors":[{"name":"Bandar Al‐Judaibi","is_ca":false},{"name":"Nilesh Chande","is_ca":false},{"name":"George K. Dresser","is_ca":true},{"name":"N. Sultan","is_ca":true},{"name":"James C. Gregor","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04990391487098689,"gpt":0.3820149494845545,"spread":0.3321110346135676,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002690234,0.0004065198,0.0008817239,0.0002245847,0.000138702,0.00001462181,0.0002388915,0.0003935898,0.0006503536],"category_scores_gemma":[0.0005415662,0.0002403114,0.0002967959,0.0004553504,0.0007102627,0.00006724444,0.00005060159,0.001415558,0.0006869431],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004187118,"about_ca_system_score_gemma":0.0001483271,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004210892,"about_ca_topic_score_gemma":0.000003119765,"domain_scores_codex":[0.9971045,0.0001296722,0.001045185,0.0006131366,0.0006362248,0.0004713451],"domain_scores_gemma":[0.9970505,0.0007375709,0.0002506493,0.0009719331,0.0001822738,0.0008071045],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001619655,0.00886513,0.542033,0.00009462317,0.002226777,0.004345449,0.0007267814,0.000002209717,0.008168927,0.009874704,0.003016454,0.4190263],"study_design_scores_gemma":[0.02574539,0.01538827,0.9059653,0.0003167834,0.002940912,0.0002945095,0.00008954584,0.0003726792,0.002479016,0.01967248,0.02635187,0.0003832622],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9773163,0.0008676988,0.00006344138,0.004385469,0.002600836,0.0006704603,0.000009470206,0.0002516835,0.01383462],"genre_scores_gemma":[0.9911297,0.0003686474,0.0003203728,0.005487669,0.001377377,0.00002498564,0.00006482957,0.00006659058,0.001159825],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4186431,"threshold_uncertainty_score":0.9799613,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2084281139","doi":"10.4137/cmt.s4456","title":"Pegylated Liposomal Doxorubicin in the Management of Ovarian Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Carboplatin; Ovarian cancer; Doxorubicin; Paclitaxel; Drug; Oncology; Pharmacology; Internal medicine; Cancer; Chemotherapy; Cisplatin","authors":[{"name":"Gabriella Ferrandina","is_ca":false},{"name":"Marco Petrillo","is_ca":false},{"name":"Angelo Licameli","is_ca":false},{"name":"Gilda Fuoco","is_ca":false},{"name":"Giovanni Scambia","is_ca":false},{"name":"Giacomo Corrado","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08930760328561985,"gpt":0.4170289362062235,"spread":0.3277213329206037,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006595929,0.0002306643,0.0006532323,0.0001126076,0.00005199562,0.000007794372,0.0002753322,0.0002181253,0.0003954185],"category_scores_gemma":[0.00002797541,0.0001172052,0.0001488291,0.0004948672,0.0004874389,0.00003645724,0.00004010318,0.0007644237,0.00001523845],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003483656,"about_ca_system_score_gemma":0.0001010158,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001948185,"about_ca_topic_score_gemma":0.0002161001,"domain_scores_codex":[0.9977317,0.0001341246,0.001018937,0.000372991,0.0004740974,0.0002680857],"domain_scores_gemma":[0.9981964,0.0005427193,0.0002268213,0.0007777425,0.0001247101,0.0001316082],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001786594,0.007841141,0.3646468,0.0006068379,0.004045561,0.001415723,0.006863791,0.000007864273,0.004743479,0.06277757,0.002064669,0.5432],"study_design_scores_gemma":[0.01155938,0.001856006,0.8854603,0.0009395987,0.001680276,0.00003835624,0.0006639452,0.0001760855,0.001041277,0.002376425,0.09401155,0.0001967559],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9432202,0.002494026,0.00002847158,0.03881187,0.001775918,0.001043274,0.00000426474,0.00003560578,0.01258639],"genre_scores_gemma":[0.9866125,0.005109447,0.000571986,0.006555249,0.0008333548,0.00008663208,0.00001252218,0.00002660705,0.0001916953],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5430032,"threshold_uncertainty_score":0.4779491,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2275755947","doi":"10.4137/cmt.s18886","title":"Stroke Prevention with Percutaneous Left Atrial Appendage Closure","year":2016,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Atrial fibrillation; Left atrial appendage occlusion; Percutaneous; Stroke (engine); Cardiology; Internal medicine; Thrombus; Occlusion; Thromboembolic stroke; Atrial Appendage; Thrombosis; Warfarin","authors":[{"name":"Peter Fahmy","is_ca":true},{"name":"Jacqueline Saw","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1523130816376864,"gpt":0.4183604860180196,"spread":0.2660474043803333,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005284171,0.0002835671,0.0007816218,0.0001403515,0.0001053128,0.00001338077,0.000150936,0.0002557699,0.0008924271],"category_scores_gemma":[0.00030126,0.0001289059,0.0003681871,0.0001524568,0.0005052057,0.0001125065,0.00004779822,0.000270742,0.0001728982],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000528408,"about_ca_system_score_gemma":0.0001135285,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000316074,"about_ca_topic_score_gemma":0.00001599145,"domain_scores_codex":[0.9974251,0.000217712,0.0009722529,0.0004542683,0.0006321637,0.0002985092],"domain_scores_gemma":[0.9975541,0.0011729,0.0003008294,0.0005451964,0.000187455,0.0002395418],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006701843,0.00009937765,0.8168716,0.00008861993,0.002063162,0.000454729,0.0005717902,0.000003233486,0.006314102,0.004309368,0.001630627,0.1608916],"study_design_scores_gemma":[0.01763014,0.01025573,0.1078485,0.000813366,0.002949485,0.0003848357,0.0003229142,0.00008052293,0.0003732304,0.003017083,0.8558216,0.0005026638],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9310915,0.001401122,0.007416347,0.04591511,0.002300432,0.001499682,0.000006409115,0.0003438042,0.01002554],"genre_scores_gemma":[0.9675637,0.001674055,0.0007898576,0.001802953,0.006339328,2.435088e-7,0.00002159606,0.00005145189,0.02175676],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8541909,"threshold_uncertainty_score":0.977145,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2007434442","doi":"10.4137/cmt.s4670","title":"Effectiveness and Safety of Rizatriptan Benzoate 10 mg in the Treatment of Migraine Headaches","year":2010,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; GDI Integrated Facility Services (Canada); Merck Canada Inc. (Canada); Montreal Neurological Institute and Hospital","funders":"","keywords":"Rizatriptan; Medicine; Migraine; Nausea; Headaches; Somnolence; Adverse effect; Anesthesia; Triptans; Prospective cohort study; Internal medicine; Sumatriptan; Surgery","authors":[{"name":"Michel Aubé","is_ca":true},{"name":"Fridon Chouha","is_ca":true},{"name":"Julie Vaillancourt","is_ca":true},{"name":"John S. Sampalis","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09138714600609213,"gpt":0.407207713880599,"spread":0.3158205678745069,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001047126,0.000232454,0.001125577,0.0001238791,0.00005692322,0.000002183868,0.0001209001,0.0001958532,0.00005149276],"category_scores_gemma":[0.0003706437,0.0001112294,0.0001850301,0.0003115085,0.001249383,0.00002406438,0.00002084898,0.0003555663,0.000001559026],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001484788,"about_ca_system_score_gemma":0.00007550188,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001266971,"about_ca_topic_score_gemma":0.0003909668,"domain_scores_codex":[0.9979162,0.0003043197,0.001016964,0.0002780776,0.0002882373,0.000196177],"domain_scores_gemma":[0.9956538,0.003360899,0.000224777,0.0004904892,0.0001748108,0.00009520147],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01190098,0.01137991,0.6559703,0.001948406,0.002890681,0.0001595954,0.05299508,0.000001264701,0.0956441,0.01178661,0.001454766,0.1538683],"study_design_scores_gemma":[0.01157667,0.01351005,0.845973,0.0004864878,0.0009466459,0.00003179817,0.001624921,0.00009378036,0.003367861,0.001948094,0.120273,0.0001677675],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9851877,0.006985574,0.00002392826,0.004842242,0.0001079621,0.0007695446,0.000005315533,0.00001349768,0.002064254],"genre_scores_gemma":[0.9893422,0.009278645,0.000145928,0.0005430283,0.0003944123,0.00001787069,0.00001098156,0.00001719924,0.000249725],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1900027,"threshold_uncertainty_score":0.4603404,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2005153650","doi":"10.4137/cmt.s3567","title":"Risperidone for Individuals with Refractory Schizophrenia","year":2010,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Risperidone; Schizophrenia (object-oriented programming); Refractory (planetary science); Antipsychotic; Clozapine; Psychiatry; Atypical antipsychotic; Medicine; Psychology","authors":[{"name":"Priya Subramanian","is_ca":true},{"name":"Abraham Rudnick","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08233823778095527,"gpt":0.4070628769732801,"spread":0.3247246391923249,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006998873,0.0003563092,0.0008866125,0.0002021289,0.000182389,0.00002351112,0.0002517243,0.0003632491,0.0002895161],"category_scores_gemma":[0.000606755,0.0001911443,0.0001994815,0.0003075614,0.0011438,0.00008763807,0.00004564262,0.001285194,0.00007772406],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003463789,"about_ca_system_score_gemma":0.0005440733,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001758656,"about_ca_topic_score_gemma":0.0001454811,"domain_scores_codex":[0.9972832,0.0001023107,0.0008231121,0.0006023001,0.0006922005,0.0004968288],"domain_scores_gemma":[0.9958652,0.001839022,0.0002198126,0.0009396048,0.0004197401,0.0007166335],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.08829377,0.006482492,0.1822395,0.000301483,0.005335095,0.0005099818,0.001118869,5.08547e-7,0.0158831,0.03017868,0.007749552,0.661907],"study_design_scores_gemma":[0.07216004,0.02599253,0.2258851,0.0004389148,0.001877272,0.0002602799,0.0002164871,0.0002270138,0.003602994,0.01244536,0.6562756,0.000618452],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.980854,0.001280993,0.0004874127,0.01308608,0.0009810216,0.001516045,0.00001369807,0.000166235,0.001614564],"genre_scores_gemma":[0.9640198,0.0007995834,0.02708284,0.003773478,0.003318729,0.0001583438,0.00008888136,0.00008695597,0.00067142],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6612886,"threshold_uncertainty_score":0.7794639,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2015849975","doi":"10.4137/cmt.s7586","title":"Early Mitoxantrone-Induced Cardiotoxicity Detected in Secondary Progressive Multiple Sclerosis","year":2011,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Mitoxantrone; Medicine; Cardiotoxicity; Multiple sclerosis; Tolerability; Internal medicine; Oncology; Ejection fraction; Natalizumab; Disease; Adverse effect; Chemotherapy; Heart failure; Immunology","authors":[{"name":"Michael Namaka","is_ca":true},{"name":"Dana Turcotte","is_ca":true},{"name":"Meghann Klowak","is_ca":true},{"name":"Christine Leong","is_ca":true},{"name":"Amy Grossberndt","is_ca":true},{"name":"J-A. Le Dorze","is_ca":true},{"name":"Michael Prout","is_ca":true},{"name":"S Andresen","is_ca":true},{"name":"Lam Vuong","is_ca":true},{"name":"Maria Melanson","is_ca":true},{"name":"Emma E. Frost","is_ca":true},{"name":"Malcolm Doupe","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3327976076464534,"gpt":0.3996232613354747,"spread":0.06682565368902127,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001044096,0.0005257595,0.001655034,0.0004245525,0.0001832127,0.00001706744,0.0004397772,0.000544714,0.000295521],"category_scores_gemma":[0.002584534,0.0003578779,0.0003151799,0.0008840156,0.001382199,0.0001674062,0.0002327071,0.001979731,0.00007112803],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001696892,"about_ca_system_score_gemma":0.0003381918,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003678306,"about_ca_topic_score_gemma":0.000188161,"domain_scores_codex":[0.9947425,0.0007066572,0.001764947,0.0009306977,0.0009683638,0.0008868693],"domain_scores_gemma":[0.9955474,0.001790726,0.0003594895,0.001060155,0.0006213054,0.0006209447],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004563356,0.002922707,0.5492953,0.0002624031,0.001976615,0.0006543383,0.01062298,2.834679e-7,0.1051717,0.00007081167,0.0005056675,0.3239537],"study_design_scores_gemma":[0.01227861,0.003907289,0.9634115,0.0009181071,0.0002655376,0.00001636023,0.0006420275,0.000262841,0.01643721,0.0001669151,0.001325188,0.0003683901],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9881307,0.002972625,0.00006762738,0.0009444034,0.0008175797,0.001957805,0.000009577266,0.0002125502,0.004887135],"genre_scores_gemma":[0.993537,0.002318064,0.001058793,0.001640046,0.001087194,0.0001801868,0.00001390064,0.00008646212,0.0000783609],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4141162,"threshold_uncertainty_score":0.9998873,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W96046762","doi":"10.4137/cmt.s9566","title":"Review of Treatment Options for Myelofibrosis: Focus on Ruxolitinib","year":2013,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Polycythaemia; Medicine; Food and drug administration; Clinical trial; Janus kinase; Janus kinase 2; Internal medicine; Pharmacology; Bone marrow","authors":[{"name":"Donal P. McLornan","is_ca":false},{"name":"John A. Laurie","is_ca":false},{"name":"Claire Harrison","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1597702826813349,"gpt":0.4327420877786614,"spread":0.2729718050973265,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002875282,0.0003590624,0.001394728,0.0001080027,0.00009181452,0.00000693131,0.0001127492,0.0001845881,0.0005570014],"category_scores_gemma":[0.0003936771,0.0001929953,0.0004547017,0.000199461,0.0003707437,0.00004766062,0.00001792357,0.000180863,0.0001259865],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001380097,"about_ca_system_score_gemma":0.0001998495,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004327562,"about_ca_topic_score_gemma":0.000005498248,"domain_scores_codex":[0.9973589,0.000171446,0.001429274,0.0004631811,0.0002748898,0.0003022866],"domain_scores_gemma":[0.9956258,0.002403573,0.0003679517,0.0006880891,0.0005829849,0.0003316149],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001498876,0.01488151,0.01889089,0.007568026,0.005868421,0.00003071299,0.001311282,0.000002903016,0.001880313,0.0835445,0.05502195,0.8095006],"study_design_scores_gemma":[0.02441031,0.0950009,0.0444775,0.04340455,0.005654364,0.00004728257,0.0003079355,0.0003328306,0.009847821,0.01804711,0.7577847,0.0006846518],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.287845,0.3647003,0.001085666,0.2743152,0.003007551,0.02607485,0.0001648184,0.0004118856,0.04239478],"genre_scores_gemma":[0.5271199,0.4187075,0.003402041,0.04502639,0.001794201,0.002475034,0.0001912273,0.00009321597,0.00119047],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.808816,"threshold_uncertainty_score":0.7870118,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2049767450","doi":"10.4137/cmt.s4120","title":"Intranasal Ciclesonide in Allergic Rhinitis","year":2010,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Ciclesonide; Medicine; Nasal administration; Nasal spray; Asthma; Dermatology; Immunology; Inhaled corticosteroids","authors":[{"name":"Harissios Vliagoftis","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07250437245537755,"gpt":0.3739266189113618,"spread":0.3014222464559842,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006685875,0.0002652645,0.0007855595,0.0002069418,0.00007718206,0.00001403499,0.0001696346,0.0004542451,0.0005991318],"category_scores_gemma":[0.0004351637,0.000186339,0.000139372,0.0003879858,0.0007062047,0.00008580723,0.00003568286,0.001452143,0.00007551933],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002829075,"about_ca_system_score_gemma":0.0001599698,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004279583,"about_ca_topic_score_gemma":0.0003943159,"domain_scores_codex":[0.9972852,0.0001608052,0.001282519,0.0004640614,0.0004533073,0.0003540318],"domain_scores_gemma":[0.9979485,0.000766117,0.0001821296,0.0005534686,0.0002195845,0.000330245],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.003484265,0.005274342,0.2185559,0.0002643731,0.001271898,0.006585348,0.01419171,0.00002619268,0.06915248,0.08117528,0.01474911,0.5852692],"study_design_scores_gemma":[0.01926533,0.003486567,0.4937531,0.00069207,0.0003925236,0.0007075529,0.001212886,0.009545475,0.001168457,0.01586864,0.453099,0.0008083922],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9577017,0.0005341647,0.000443973,0.01985713,0.002173785,0.0004290978,0.000001259287,0.0001191346,0.0187397],"genre_scores_gemma":[0.9764078,0.003107983,0.0009133273,0.01709089,0.00200072,0.000008407508,0.0000426666,0.00004976148,0.0003784352],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5844607,"threshold_uncertainty_score":0.7598684,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}